Loading...
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors prevent cell growth and have shown benefit in the treatment of metastatic colorectal cancer, whether used as single agents or in combination with chemotherapy. Clear benefit has been shown in trials of EGFR monoclonal antibodies (EGFR MA...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2017
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481896/ https://ncbi.nlm.nih.gov/pubmed/28654140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007047.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|